Urodynamics in patients with multiple sclerosis: is it necessary? A randomized-controlled trial.

Area of Science:

• Urology
• Neurology
• Clinical Research

Background:

• The role of urodynamic evaluation in Multiple Sclerosis (MS) patients experiencing Lower Urinary Tract Symptoms (LUTS) remains unclear.
• Establishing the necessity of comprehensive urodynamic studies for this patient group is crucial.

Purpose of the Study:

• To investigate the impact of urodynamic evaluation on treatment outcomes for MS patients with LUTS.
• To compare the effectiveness of standard evaluation versus urodynamic studies in managing LUTS in MS.

Main Methods:

• Recruited MS patients with LUTS, assessing symptoms and quality of life via questionnaires.
• Randomized patients into two groups: Group A (uroflowmetry) and Group B (urodynamic study).
• Treatment was administered based on evaluations, with outcomes assessed at 1, 3, and 6 months.

Main Results:

• Fifty MS patients with LUTS were randomized (25 per group).
• Both groups showed significant symptom score reductions after 6 months (p < 0.05).
• No significant differences in treatment outcomes were observed between the uroflowmetry and urodynamic study groups at any follow-up point (p > 0.05).

Conclusions:

• Non-invasive clinical evaluation is adequate for effective LUTS treatment in MS patients.
• Urodynamic studies do not significantly alter treatment response regarding LUTS severity, bother, or quality of life.